drugset / Trial / NCT06147505
XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
NaSingle-groupOpen-labelTreatment
Summary
The main objective of this clinical study is to evaluate the safety of XS005 injection; to determine the maximum tolerated dose . Furthermore, initial efficacy will be examined.
Timeline
- Start
- 2023-10-29
- Primary completion
- 2025-11-02
- Completion
- 2025-12-29
Outcome
Outcome not reported
Stopped: “The hospital is under renovation”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XS005 | Unknown | — | — |